IN8bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IN8bio and other ETFs, options, and stocks.

About INAB

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. 

CEO
William T. Ho
CEOWilliam T. Ho
Employees
18
Employees18
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2016
Founded2016
Employees
18
Employees18

INAB Key Statistics

Market cap
7.77M
Market cap7.77M
Price-Earnings ratio
-0.15
Price-Earnings ratio-0.15
Dividend yield
Dividend yield
Average volume
234.10K
Average volume234.10K
High today
$2.30
High today$2.30
Low today
$2.20
Low today$2.20
Open price
$2.25
Open price$2.25
Volume
187.36K
Volume187.36K
52 Week high
$27.60
52 Week high$27.60
52 Week low
$2.06
52 Week low$2.06

People also own

Based on the portfolios of people who own INAB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.